Research
Our research interests span from oncology to environment. The common thread is exploiting hybrid nanotechnologies.
Nanomaterials development
After the introduction of the ultrasmall-in-nano approach for the design of non-persistent plasmonic nanotherapeutics, we are constantly develop new hybrid nanomaterials for application in oncology, communicable diseases, and catalisys.
Oncology & NanoToxicology
Our efforts are devoted to the establishment of non-invasive treatments of neoplasms and to shed light on the nano/bio-interactions. Our special focus is on nanomaterials-mediated adjuvant photo/chemo- or chemo/radio-treatment of head and neck, and pancreatic carcinomas.
Alternative BioModels
In agreement to the European Parliament Directive 2010/63/EU and the the 3Rs (Reduction, Refinement, Replacement) principle, we established alternative biomodels based on multicellular tumor spheroids and chicken chorioallantoic membrane (CAM) for advanced oncological investigations and the screening of the most promising emergent treatments.
Catalysis
We are committed to the development of hybrid nanocatalysts for hydrogen storage and carbon dioxide capture.
Collaborations
-
Pisa University Hospital (Pisa, IT)
-
German Cancer Research Center (Heidelberg, DE)
-
Gustave-Roussy Hospital (Paris, FR)
-
VUmc Cancer Center Amsterdam (Amsterdam, NL)
-
Children's Cancer Institute (Sydney, AU)
-
University of Pisa (Pisa, IT)